NCT03384914 2026-03-06
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
Boston Scientific Corporation
University of Oklahoma
H. Lee Moffitt Cancer Center and Research Institute